Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Enalapril in children with Alport syndrome.

Proesmans W, Van Dyck M.

Pediatr Nephrol. 2004 Mar;19(3):271-5. Epub 2004 Jan 24.

PMID:
14745635
2.

Enalapril in paediatric patients with Alport syndrome: 2 years' experience.

Proesmans W, Knockaert H, Trouet D.

Eur J Pediatr. 2000 Jun;159(6):430-3.

PMID:
10867848
3.

Enalapril: antiproteinuric effect in children with nephrotic syndrome.

Lama G, Luongo I, Piscitelli A, Salsano ME.

Clin Nephrol. 2000 Jun;53(6):432-6.

PMID:
10879662
4.

Enalapril and prednisone in children with nephrotic-range proteinuria.

Delucchi A, Cano F, Rodriguez E, Wolff E, Gonzalez X, Cumsille MA.

Pediatr Nephrol. 2000 Oct;14(12):1088-91.

PMID:
11045392
5.

Angiotensin converting enzyme inhibitor therapy in children with Alport syndrome: effect on urinary albumin, TGF-beta, and nitrite excretion.

Adler L, Mathew R, Futterweit S, Frank R, Gauthier BG, Kashtan CE, Trachtman H.

BMC Nephrol. 2002 Feb 14;3:2.

6.

The effects of amlodipine and enalapril on renal function in adults with hypertension and nondiabetic nephropathies: a 3-year, randomized, multicenter, double-blind, placebo-controlled study.

Esnault VL, Brown EA, Apetrei E, Bagon J, Calvo C, DeChatel R, Holdaas H, Krcmery S, Kobalava Z; Amlodipine Versus Enalapril in Renal failure (AVER) Study Group.

Clin Ther. 2008 Mar;30(3):482-98. doi: 10.1016/j.clinthera.2008.03.006.

PMID:
18405787
7.

Enalapril dosage in progressive chronic nephropathy: a randomised, controlled trial.

Elung-Jensen T, Heisterberg J, Sonne J, Strandgaard S, Kamper AL.

Eur J Clin Pharmacol. 2005 Apr;61(2):87-96. Epub 2005 Mar 11.

PMID:
15761754
8.

Losartan and enalapril are comparable in reducing proteinuria in children with Alport syndrome.

Webb NJ, Shahinfar S, Wells TG, Massaad R, Gleim GW, McCrary Sisk C, Lam C.

Pediatr Nephrol. 2013 May;28(5):737-43. doi: 10.1007/s00467-012-2372-9. Epub 2012 Dec 4.

PMID:
23207876
9.

Cyclosporine A treatment in patients with Alport syndrome: a single-center experience.

Massella L, Muda AO, Legato A, Di Zazzo G, Giannakakis K, Emma F.

Pediatr Nephrol. 2010 Jul;25(7):1269-75. doi: 10.1007/s00467-010-1484-3. Epub 2010 Mar 18.

PMID:
20238228
10.

ACE inhibitorenalapril diminishes albuminuria in patients with cystinosis.

Levtchenko E, Blom H, Wilmer M, van den Heuvel L, Monnens L.

Clin Nephrol. 2003 Dec;60(6):386-9.

PMID:
14690254
11.

Nephropathy of cyanotic congenital heart disease: clinical characteristics and effectiveness of an angiotensin-converting enzyme inhibitor.

Fujimoto Y, Matsushima M, Tsuzuki K, Okada M, Shibata M, Yanase Y, Usui K, Nagashima M.

Clin Nephrol. 2002 Aug;58(2):95-102.

PMID:
12227694
12.

Renoprotection by ACE inhibitors after severe hemolytic uremic syndrome.

Van Dyck M, Proesmans W.

Pediatr Nephrol. 2004 Jun;19(6):688-90. Epub 2004 Apr 3.

PMID:
15064939
13.
14.

High serum enalaprilat in chronic renal failure.

Elung-Jensen T, Heisterberg J, Kamper AL, Sonne J, Strandgaard S, Larsen NE.

J Renin Angiotensin Aldosterone Syst. 2001 Dec;2(4):240-5.

PMID:
11881130
15.

Effect of enalapril on proteinuria after kidney transplantation.

Rell K, Linde J, Morzycka-Michalik M, Gaciong Z, Lao M.

Transpl Int. 1993;6(4):213-7.

PMID:
8347267
16.

Enalapril dosage in steroid-resistant nephrotic syndrome.

Bagga A, Mudigoudar BD, Hari P, Vasudev V.

Pediatr Nephrol. 2004 Jan;19(1):45-50. Epub 2003 Nov 25.

PMID:
14648339
17.

The effect of aldosterone blockade in patients with Alport syndrome.

Kaito H, Nozu K, Iijima K, Nakanishi K, Yoshiya K, Kanda K, Przybyslaw Krol R, Yoshikawa N, Matsuo M.

Pediatr Nephrol. 2006 Dec;21(12):1824-9. Epub 2006 Oct 13.

PMID:
17039334
18.

Treatment of X-linked hereditary nephritis in Samoyed dogs with angiotensin converting enzyme (ACE) inhibitor.

Grodecki KM, Gains MJ, Baumal R, Osmond DH, Cotter B, Valli VE, Jacobs RM.

J Comp Pathol. 1997 Oct;117(3):209-25.

PMID:
9447482
19.

Long-term therapy with enalapril in patients with nephrotic-range proteinuria.

Proesmans W, Wambeke IV, Dyck MV.

Pediatr Nephrol. 1996 Oct;10(5):587-9.

PMID:
8897561
20.

Enalapril and hydroxyurea therapy for children with sickle nephropathy.

Fitzhugh CD, Wigfall DR, Ware RE.

Pediatr Blood Cancer. 2005 Dec;45(7):982-5.

PMID:
15704213

Supplemental Content

Support Center